Janux Therapeutics, Inc.

NASDAQ:JANX

54.21 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -28.059-5.959-14.76-11.758-11.568-17.508-17.459-16.065-16.696-16.888-13.41-13.416-10.766-6.206-2.284-1.655-1.256-2.46-1.413
Depreciation & Amortization 0.510.5060.5320.5310.50.4710.4530.4030.2490.1080.0810.0640.0270.0130.0090.0090.0010.0010.002
Deferred Income Tax 00000000000-13.4890000000
Stock Based Compensation 15.3875.7575.6254.4834.5485.5015.4734.2054.5964.4443.9582.9442.5661.2770.1230.040.0280.0020.002
Change In Working Capital 11.799-7.352-4.447-1.096-3.081-1.677-0.70.836-0.7956.362-2.127-0.0152.398-1.2567.715-0.0230.1440.322-0.054
Accounts Receivables 7.5-6.981-0.519000.75-0.750.5-0.50000.37507.625-8000
Change In Inventory 0000.750-0.750000000.2260-0.2530000
Change In Accounts Payables 1.175-0.694-0.4560.3270.228-0.171-0.1070.223-0.6340.857-0.74-0.4822.584-0.310.347-0.1980.0450.236-0.069
Other Working Capital 3.1490.323-3.472-1.423-3.309-1.5060.1570.1130.3395.505-1.3870.467-0.787-0.946-0.0048.1750.0990.0860.015
Other Non Cash Items -1.86811.4715.877-2.061-2.108-1.841-1.678-1.292-0.768-0.099-0.02413.431-0.079-0.032-7.8317.8020.0451.3540.587
Operating Cash Flow -2.231-10.021-14.837-9.901-11.709-15.054-13.911-11.913-13.414-6.073-11.522-10.481-5.854-6.2045.563-1.629-1.083-0.781-0.876
Investing Activities:
Investments In Property Plant And Equipment -0.025-0.095-0.197-0.515-0.47-0.58-0.285-2.056-2.52-0.898-0.971-1.173-0.077-0.079-0.1530000
Acquisitions Net 000-11.63860.981-18.4548.455-0.452-22.283-9.9370-120.3730000000
Purchases Of Investments -32.466-235.54-178.539-33.112-135.981-76.546-71.705-86.048-94.467-68.813-45.061-103.501-227.607-142.51800000
Sales Maturities Of Investments 45.16544.756544.75759563.2586.5116.7578.7577.111222.145000000
Other Investing Activites 0-190.79-113.53911.638-60.98118.454-8.4550.45222.2839.93732.039120.37322.145-142.51800000
Investing Cash Flow 12.674-190.885-113.73611.123-61.45117.874-8.74-1.60419.7639.03931.0687.326-205.539-142.597-0.1530000
Financing Activities:
Debt Repayment 0000000000000000000
Common Stock Issued -4.8772.765322.1710.83156.6090.5281.580.500.3080.00156.565-0.843329.65757.5460000
Common Stock Repurchased 000000000000-0.843000000
Dividends Paid 0000000000000000000
Other Financing Activities 6.5262.765322.1710.83156.6090.5281.58-0.30900.3080.001-56.4010329.65757.5464.553-0.0335.51.504
Financing Cash Flow 1.6492.765322.1710.83156.6090.5281.580.19100.3080.0010.164-0.843329.65757.5464.553-0.0335.51.504
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000
Net Change In Cash 12.908-198.141193.5982.053-16.5513.348-21.071-13.3266.3493.27419.547-2.991-212.236180.85662.9562.924-1.1164.7190.628
Cash At End Of Period 27.5714.662212.80320.02117.96834.51931.17152.24265.56859.21955.94536.39839.389251.62570.7697.8134.8896.0051.286